Clinical pathway for the diagnosis and treatment of marginal zone lymphoma
Marginal zone lymphoma(MZL)is a common indolent lymphoma characterized by complex and di-verse clinical symptoms,non-specific pathology,strong heterogeneity,difficult clinical diagnosis,and significant variation in treatment options.To further promote the standardized diagnosis and treatment of MZL,an expert team specializing in indolent lymphoma from central and southwest China,referencing both domestic and interna-tional guidelines/consensuses and integrating them with clinical practice in China,has developed and released this clinical diagnosis and treatment pathway.This document provides a detailed elaboration on the clinical manifesta-tions,laboratory tests,diagnosis and differential diagnosis,staging and prognosis,and stratified treatment of the three main subtypes of MZL.Notably,it offers a standardized diagnostic and treatment process recommendation for each subtype in an intuitive roadmap format,facilitating reference for frontline and primary care medical per-sonnel,thereby collectively enhancing the level of MZL diagnosis and treatment in China.
marginal zone lymphomaclassificationdiagnosistreatmentclinical pathway
万方数据
维普
